comparemela.com

Latest Breaking News On - Pharma aktiebolag - Page 1 : comparemela.com

Karo Pharma receives approval to delist the Company s share from Nasdaq Stockholm in connection with the change of listing venue to Nasdaq First North Growth Market

HUDDINGE, Sweden, March 10, 2022 /PRNewswire/ Karo Pharma Aktiebolag (publ) (the "Company" or "Karo Pharma") announced in a press release on 9 March 2022 that Karo Pharma's Board of Directors

Karo pharmaChristoffer lorenzenJon johnssonPrnewswire karo pharma aktiebolagCompany or karo pharmaPharma aktiebolagNasdaq stockholmNasdaq stockholm first north growth marketNasdaq first north growthNasdaq first north growth marketNasdaq stockholm large

Karo Pharma completes the acquisition of Sylphar International NV

HUDDINGE, Sweden, Jan. 13, 2022 /PRNewswire/ Karo Pharma Aktiebolag ("Karo") today announces that the previously announced acquisition of the Belgian fast-growing digital-first brand company

Karo pharmaChristoffer lorenzenCarl lindgrenKaro pharma aktiebolagSylphar international nvVp business developmentKaro corporate management teamPharma aktiebolagSylphar internationalRobin list

Karo Pharma enters into an agreement for the potential acquisition of the E45 brand from Reckitt

HUDDINGE, Sweden, Dec. 24, 2021 /PRNewswire/ Karo Pharma Aktiebolag ("Karo") has today entered into a put option agreement pursuant to which it may acquire the dermatology brand E45 from

United kingdomKaro pharmaChristoffer lorenzenAnna haleCarl lindgrenVp business developmentPharma aktiebolagSouth africaNasdaq stockholm mid

Karo Pharma enters into an agreement for the potential acquisition of the E45® brand from Reckitt

/PRNewswire/ Karo Pharma Aktiebolag ("Karo") has today entered into a put option agreement pursuant to which it may acquire the dermatology brand E45® from.

United kingdomKaro pharmaChristoffer lorenzenAnna haleCarl lindgrenVp business developmentPharma aktiebolagSouth africaNasdaq stockholm mid

Karo Pharma acquires Sylphar International NV for EUR 290m and intends to carry out a rights issue of approximately EUR 200-250m

HUDDINGE, Sweden, Nov. 23, 2021 /PRNewswire/ Karo Pharma Aktiebolag (publ) (the "Company" or "Karo") has today entered into an agreement to acquire all of the shares in Sylphar International

United kingdomKaro pharmaChristoffer lorenzenCarl lindgrenKaro pharma aktiebolagPrnewswire karo pharma aktiebolagSylphar international nvVp business developmentPro teeth whitening co limitedSylphar groupNutravita limitedCompany or karoPharma aktiebolagSylphar internationalAlpha foodsVendis capital

vimarsana © 2020. All Rights Reserved.